Shahrokh F. Shariat
University of Texas Southwestern Medical Center
CancerInternal medicineUrologySurgeryOncologyStage (cooking)Hazard ratioCystectomyRenal cell carcinomaCarcinomaDiseaseProstatectomyProstate cancerBladder cancerLymph nodeIn patientUrothelial carcinomaProportional hazards modelMedicineCohort
Publications 1952
#1Giovanni Cacciamani (SC: University of Southern California)H-Index: 17
Last. Maria J. Ribal (University of Barcelona)H-Index: 35
view all 12 authors...
Abstract null null The association between tobacco use and urothelial cancer of the bladder is well known. Given the worsening tobacco epidemic, here we make the case for systematic targeted points of intervention for urologists and other professionals to intervene against bladder cancer. Awareness of contemporary checkpoints where we can intervene for counseling patients may help medical education in a tobacco-pandemic difficult setting.
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 7
#2Keiichiro Mori (Jikei University School of Medicine)H-Index: 8
Last. Dmitry EnikeevH-Index: 12
view all 11 authors...
ABSTRACT null null Introduction null The present systematic review and network meta-analysis (NMA) of randomized controlled trials (RCTs) aimed to compare the mortality rates related to adverse events (AEs) and discontinuation of treatment due to toxicity as well as all AEs of currently used chemotherapy regimens for first-line therapy of advanced or metastatic urothelial carcinoma of the bladder (UCB). null null null Material and methods null The MEDLINE and EMBASE databases were searched for a...
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 7
#2Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
Last. Nico С. Grossmann (UZH: University of Zurich)
view all 23 authors...
Elevated preoperative plasma level of endoglin has been associated with worse oncologic outcomes in various malignancies. The present large-scale study aimed to determine the predictive and prognostic values of preoperative endoglin with regard to clinicopathologic and survival outcomes in patients treated with radical cystectomy (RC) for nonmetastatic urothelial carcinoma of the bladder (UCB). We prospectively collected preoperative blood samples from 1036 consecutive patients treated with RC f...
#1Francesco Chierigo (UniGe: University of Genoa)H-Index: 8
#2M. Wenzel (UdeM: Université de Montréal)
Last. M. Gallucci (Policlinico Umberto I)H-Index: 2
view all 16 authors...
Purpose:Our goal was to compare cancer specific mortality (CSM) rates between radical prostatectomy (RP) vs external beam radiotherapy (EBRT) in National Comprehensive Cancer Network© (NCCN©) high ...
#1Keiichiro Mori (Jikei University School of Medicine)H-Index: 8
#2Manuela Schmidinger (Medical University of Vienna)H-Index: 28
Last. Shahrokh F. Shariat (Medical University of Vienna)H-Index: 132
view all 5 authors...
#1Tim Wollenweber (Medical University of Vienna)H-Index: 3
Last. Chrysoula VrakaH-Index: 7
view all 14 authors...
Background: [177Lu]Lu-PSMA-617 radioligand therapy (PSMA-RLT) could affect kidney and salivary gland functions in metastatic castration-resistant prostate cancer (mCRPC) patients. Methods: We retrospectively analyzed clinical, renal, and salivary scintigraphy data and salivary [68Ga]Ga-PSMA-11 ligand PET scan measures such as metabolic volume and SUVmax values of 27 mCRPC men (mean age 71 ± 7 years) before and 4 weeks after receiving three cycles of PSMA-RLT every 4 weeks. Twenty-two patients ad...
#1Christoph Würnschimmel (UdeM: Université de Montréal)H-Index: 3
#2M. Wenzel (UdeM: Université de Montréal)
Last. Carlo Terrone (UniGe: University of Genoa)H-Index: 29
view all 15 authors...
Objectives null To test the effect of race/ethnicity on cancer-specific mortality after radical prostatectomy or external beam radiotherapy in localized prostate cancer patients. null Methods null In the Surveillance, Epidemiology and End Results database 2004-2016, we identified intermediate-risk and high-risk white (n = 151 632), Asian (n = 11 189), Hispanic/Latino (n = 20 077) and African American (n = 32 550) localized prostate cancer patients, treated with external beam radiotherapy or radi...
1 CitationsSource
#1Hadi Mostafaei (Tabriz University of Medical Sciences)H-Index: 8
#2Hanieh Salehi-Pourmehr (Tabriz University of Medical Sciences)H-Index: 6
Last. Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
view all 18 authors...
Abstract null null Context null The choice of the most efficacious drug for patients with idiopathic overactive bladder (IOAB) remains challenging. null null null Objective null The aim of this network meta-analysis was to determine the most efficacious oral antimuscarinic or β-adrenoceptor agonist accounting for adverse events for the management of IOAB. null null null Evidence acquisition null A comprehensive electronic search was done in MEDLINE, EMBASE, Cochrane Central Register of Controlle...
#7Felix K.-H. ChunH-Index: 69
#8Alberto Briganti (UniSR: Vita-Salute San Raffaele University)H-Index: 96
Last. Aly-Khan A. Lalani (McMaster University)H-Index: 12
view all 20 authors...
INTRODUCTION AND OBJECTIVE:Four recent first line clinical trials that leverage immune-oncology agents have demonstrated an overall survival benefit relative to sunitinib. However, formal network m...
#2Daniela Muhr (Medical University of Vienna)H-Index: 6
Last. Yen Y. TanH-Index: 16
view all 7 authors...
BACKGROUND: Men with germline BRCA1/2 mutations are not well studied compared to their female counterparts. This study evaluates the cancer characteristics, family history of cancer, and outcomes of male BRCA1/2 mutation carriers. METHODS: All men with germline BRCA1/2 mutations who attended genetic assessment between October 1995 and October 2019 at the Medical University of Vienna were identified. Clinicohistopathological features, family history of cancer, and outcomes were assessed by mutati...